Neutrophil to lymphocyte ratio predicts risk of nodal involvement in T1 colorectal cancer patients.
暂无分享,去创建一个
M. Ciccozzi | S. Angeletti | R. Coppola | C. Coco | G. Rizzo | D. Caputo | A. Coppola | V. La Vaccara | Vincenzo La Vaccara
[1] E. Ruíz-García,et al. Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy , 2016, Medical archives.
[2] A. Khan,et al. The Neutrophil-to-Lymphocyte Ratio as a Marker of Lymph Node Status in Patients with Rectal Cancer , 2016, Oncology.
[3] D. Coit,et al. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma , 2016, Annals of surgery.
[4] P. Gibbs,et al. Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival. , 2015, Clinical colorectal cancer.
[5] J. Knox,et al. Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer. , 2015, Clinical genitourinary cancer.
[6] M. Orditura,et al. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis. , 2015, Surgery.
[7] J. Yue,et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer , 2015, Tumor Biology.
[8] Y. Toiyama,et al. Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery , 2015, Digestive Diseases and Sciences.
[9] Peng Wang,et al. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[10] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[11] Y. Toiyama,et al. Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery. , 2015, International surgery.
[12] N. Kim,et al. Clinical Implications of Microsatellite Instability in T1 Colorectal Cancer , 2014, Yonsei medical journal.
[13] Y. Kim,et al. Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer , 2014, BMC Surgery.
[14] Yu-qin Pan,et al. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients , 2014, Medical Oncology.
[15] O. Faiz,et al. A Preoperative Neutrophil to Lymphocyte Ratio of 3 Predicts Disease-Free Survival After Curative Elective Colorectal Cancer Surgery , 2014, Annals of surgery.
[16] Y. Hirose,et al. Predictors of Lymph Node Metastasis in T1 Colorectal Carcinoma: An Immunophenotypic Analysis of 265 Patients , 2014, Diseases of the colon and rectum.
[17] K. Leong,et al. Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation , 2014, The British journal of surgery.
[18] H. Ueno,et al. Impact of the perioperative neutrophil-to-lymphocyte ratio on the long-term survival following an elective resection of colorectal carcinoma , 2014, International Journal of Colorectal Disease.
[19] J. Coffey,et al. Ratios derived from an array of standard haematological indices predict the oncological outcome in colon cancer , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[20] A. Jemal,et al. Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.
[21] C. Taffon,et al. T1 colorectal cancer: poor histological grading is predictive of lymph-node metastases. , 2014, International journal of surgery.
[22] K. Gungorduk,et al. Can preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios be used as predictive markers for lymph node metastasis in squamous cell carcinoma of the vulva? , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[23] H. Samonigg,et al. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer. , 2013, Anticancer research.
[24] H. Samonigg,et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients , 2013, British Journal of Cancer.
[25] Y. Iwasaki,et al. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer , 2013, British Journal of Cancer.
[26] S. Grossman,et al. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme , 2013, Journal of Neuro-Oncology.
[27] S. Mallappa,et al. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[28] R. Soetikno,et al. Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis , 2013, Surgical Endoscopy.
[29] K. Pummer,et al. Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients , 2013, British Journal of Cancer.
[30] C. Antonescu,et al. Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor , 2013, Annals of Surgical Oncology.
[31] L. Tho,et al. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[32] D. McMillan,et al. The Relationships between Body Composition and the Systemic Inflammatory Response in Patients with Primary Operable Colorectal Cancer , 2012, PloS one.
[33] S. Albelda,et al. Tumor-associated neutrophils: friend or foe? , 2012, Carcinogenesis.
[34] Jeong-Won Lee,et al. Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. , 2012, Anticancer research.
[35] C. Sautès-Fridman,et al. The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.
[36] R. Tang,et al. Effect of preoperative neutrophil–lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy , 2011, International Journal of Colorectal Disease.
[37] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[38] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[39] A. Nicholson,et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.
[40] J. Galon,et al. The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. , 2007, Cancer research.
[41] R. Sinha,et al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. , 2006, Cancer research.
[42] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[43] R. Nozaki,et al. Management of early invasive colorectal cancer , 1995, Diseases of the colon and rectum.
[44] K. Hase,et al. Long-term results of curative resection of “minimally invasive” colorectal cancer , 1995, Diseases of the colon and rectum.
[45] P. Hermanek,et al. Early (microinvasive) colorectal carcinoma , 1986, International Journal of Colorectal Disease.
[46] Qiaojia Huang,et al. The Value of Preoperative Neutrophil to Lymphocyte Ratio in Indicating Lymph Node Metastasis in Patients with Resectable T2 Stage Gastric Adenocarcinoma. , 2016, Clinical laboratory.
[47] H. Bostanci,et al. Neutrophil-lymphocyte ratio as a predictive factor for tumor staging in colorectal cancer. , 2014, Turkish journal of medical sciences.
[48] M. Büchler,et al. Radical Surgery with Total Mesorectal Excision in Patients with T1 Rectal Cancer , 2014, Annals of Surgical Oncology.
[49] C. Mathers,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .
[50] H. Ohtani. Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. , 2007 .
[51] H. Ohtani,et al. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. , 2007, Cancer immunity.